These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 35788737)

  • 1. Oral Cryotherapy for Oral Mucositis in Patients Receiving Busulfan: A Retrospective/Prospective Descriptive Study.
    Grossman A; Froggatt N; Hendricks L; Kannenberg M; Klink K; Koch N; Reid K; Pitcher D; Bullock P; Neubauer J
    Oncol Nurs Forum; 2022 Jun; 49(4):327-335. PubMed ID: 35788737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral cryotherapy for oral mucositis management in patients receiving allogeneic hematopoietic stem cell transplantation: a prospective randomized study.
    Lu Y; Zhu X; Ma Q; Wang J; Jiang P; Teng S; Zhou L; Wu D; Wang H
    Support Care Cancer; 2020 Apr; 28(4):1747-1754. PubMed ID: 31302767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of oral mucositis with cryotherapy in children undergoing hematopoietic stem cell transplantations-a feasibility study and randomized controlled trial.
    Kamsvåg T; Svanberg A; Legert KG; Arvidson J; von Essen L; Mellgren K; Toporski J; Winiarski J; Ljungman G
    Support Care Cancer; 2020 Oct; 28(10):4869-4879. PubMed ID: 31993753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Caphosol(®) mouthwash gives no additional protection against oral mucositis compared to cryotherapy alone in stem cell transplantation. A pilot study.
    Svanberg A; Öhrn K; Birgegård G
    Eur J Oncol Nurs; 2015 Feb; 19(1):50-3. PubMed ID: 25224595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness and safety of oral cryotherapy in the prevention of oral mucositis after conditioning regimens with high-dose melphalan for autologous stem cell transplantation for lymphoma and myeloma.
    Batlle M; Morgades M; Vives S; Ferrà C; Oriol A; Sancho JM; Xicoy B; Moreno M; Magallón L; Ribera JM
    Eur J Haematol; 2014 Dec; 93(6):487-91. PubMed ID: 24889275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effect of cryotherapy against oral mucositis among allogeneic hematopoietic stem cell transplant recipients using melphalan-based conditioning.
    Oku S; Futatsuki T; Imamura Y; Hikita H; Inada A; Mizutani S; Mori Y; Kashiwazaki H
    Support Care Cancer; 2023 Aug; 31(9):521. PubMed ID: 37581845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retrospective study of the digestive tract mucositis derived from myeloablative and non-myeloablative/reduced-intensity conditionings with busulfan in hematopoietic cell transplantation patient.
    Eduardo FP; Bezinelli LM; Gobbi M; Rosin FCP; Carvalho DLC; Ferreira MH; da Silva CC; Hamerschlak N; Corrêa L
    Support Care Cancer; 2019 Mar; 27(3):839-848. PubMed ID: 30109488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Icing oral mucositis: Oral cryotherapy in multiple myeloma patients undergoing autologous hematopoietic stem cell transplant.
    Chen J; Seabrook J; Fulford A; Rajakumar I
    J Oncol Pharm Pract; 2017 Mar; 23(2):116-120. PubMed ID: 26684614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Incidence and Severity of Oral Mucositis among Allogeneic Hematopoietic Stem Cell Transplantation Patients: A Systematic Review.
    Chaudhry HM; Bruce AJ; Wolf RC; Litzow MR; Hogan WJ; Patnaik MS; Kremers WK; Phillips GL; Hashmi SK
    Biol Blood Marrow Transplant; 2016 Apr; 22(4):605-616. PubMed ID: 26409924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ice-cream used as cryotherapy during high-dose melphalan conditioning reduces oral mucositis after autologous hematopoietic stem cell transplantation.
    Jasiński M; Maciejewska M; Brodziak A; Górka M; Skwierawska K; Jędrzejczak WW; Tomaszewska A; Basak GW; Snarski E
    Sci Rep; 2021 Nov; 11(1):22507. PubMed ID: 34795377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of cryotherapy associated with laser therapy for decreasing severity of melphalan-induced oral mucositis during hematological stem-cell transplantation: a prospective clinical study.
    de Paula Eduardo F; Bezinelli LM; da Graça Lopes RM; Nascimento Sobrinho JJ; Hamerschlak N; Correa L
    Hematol Oncol; 2015 Sep; 33(3):152-8. PubMed ID: 24519448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of Photobiomodulation and Oral Cryotherapy on Oral Mucositis Among Patients Undergoing Chemotherapy Conditioning Prior to Hematological Stem Cell Transplantation.
    Chan X; Tay L; Yap SJ; Wu VX; Klainin-Yobas P
    Semin Oncol Nurs; 2023 Jun; 39(3):151405. PubMed ID: 36935333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced intensity conditioning and oral care measures prevent oral mucositis and reduces days of hospitalization in allogeneic stem cell transplantation recipients.
    Legert KG; Remberger M; Ringdén O; Heimdahl A; Dahllöf G
    Support Care Cancer; 2014 Aug; 22(8):2133-40. PubMed ID: 24647488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral cryotherapy for management of chemotherapy-induced oral mucositis in haematopoietic cell transplantation: a systematic review.
    Alsulami FJ; Shaheed SU
    BMC Cancer; 2022 Apr; 22(1):442. PubMed ID: 35459129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cryotherapy effect on oral mucositis severity among recipients of bone marrow transplantation: a literature review.
    Tayyem AQ
    Clin J Oncol Nurs; 2014 Aug; 18(4):E84-7. PubMed ID: 25095309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New photobiomodulation protocol prevents oral mucositis in hematopoietic stem cell transplantation recipients-a retrospective study.
    Weissheimer C; Curra M; Gregianin LJ; Daudt LE; Wagner VP; Martins MAT; Martins MD
    Lasers Med Sci; 2017 Dec; 32(9):2013-2021. PubMed ID: 28840382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The risk factors for oral mucositis and the effect of cryotherapy in patients after the BEAM and HD-l-PAM 200 mg/m(2) autologous hematopoietic stem cell transplantation.
    Vokurka S; Bystricka E; Scudlova J; Mazur E; Visokaiova M; Vasilieva E; Brandejsova R; Chvojkova I; Vrabcova M; Vitkova J; Mjartanova D; Vodickova M; Bockova J; Streinerova K
    Eur J Oncol Nurs; 2011 Dec; 15(5):508-12. PubMed ID: 21310656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective oral mucositis audit: oral mucositis in patients receiving high-dose melphalan or BEAM conditioning chemotherapy--European Blood and Marrow Transplantation Mucositis Advisory Group.
    Blijlevens N; Schwenkglenks M; Bacon P; D'Addio A; Einsele H; Maertens J; Niederwieser D; Rabitsch W; Roosaar A; Ruutu T; Schouten H; Stone R; Vokurka S; Quinn B; McCann S;
    J Clin Oncol; 2008 Mar; 26(9):1519-25. PubMed ID: 18268357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant human epidermal growth factor on oral mucositis induced by intensive chemotherapy with stem cell transplantation.
    Kim KI; Kim JW; Lee HJ; Kim BS; Bang SM; Kim I; Oh JM; Yoon SS; Lee JS; Park S; Kim BK
    Am J Hematol; 2013 Feb; 88(2):107-12. PubMed ID: 23225026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Economic and clinical aspects of intravenous versus oral busulfan in adult patients for conditioning prior to HSCT.
    Berger K; Schopohl D; Rieger C; Ostermann H
    Support Care Cancer; 2015 Dec; 23(12):3447-54. PubMed ID: 25773673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.